Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Monday 12 July 2021 10:03 am  |  Updated:  Monday 12 July 2021 10:16 am

Tech giants Foxconn, TSMC to buy 10m covid vaccines for Taiwan

By: Cyrus Chan

Add as a preferred source on Google
Pop-up Vaccine Centre Opens In Newcastle
Longgang Liu, 24 receives a Covid-19 vaccine

Two of the world’s largest tech firms Foxconn and TSMC inked an agreement worth £252m for buying 10m doses of Pfizer/BioNTech Covid-19 vaccine for Taiwan.

The deal announced on Monday in a statement by BioNTech’s Chinese sales agent Shanghai Fosun Pharmaceutical Group.

Under the agreement, Taiwanese firms Foxconn and Taiwan Semiconductor Manufacturing Co (TSMC) will buy 5m doses of the vaccine respectively and donate to the government for local vaccination.

Taiwan’s government has been trying for months to buy the vaccine directly from the German manufacturer and blamed China to block the deal.

China, which claimed the self-ruled island as its own territory, denied the accusations.

This highly politicised deal came after the Taiwanese government agreed to allow Foxconn and TSMC, both major Apple suppliers, to negotiate the vaccines on its behalf.

In a statement to Taiwan Stock Exchange, TSMC said 5m doses of Pfizer vaccine will be donated to the Taiwan Centers for Disease Control.

“The donation is an emergency relief made for public welfare due to natural disasters,” the chip manufacturer said.

Meanwhile, Foxconn’s billionaire founder Terry Gou wrote on his Facebook page that he is gratified to seal the deal.

Gou emphasised Beijing did not interfere with the vaccine procurement.

Taiwan’s government has faced intensified pressure from the public to accelerate the vaccination programme as only 0.3 per cent of its population is fully vaccinated.

The US and Japan donated almost 5m covid vaccine jabs to Taiwan, while the island has ordered millions of vaccines, mainly from AstraZeneca and Moderna.

Read more

Apple memory chip warning causes fresh Asia tech sell-off

Apple App Store with UK flag and warning sign about potential scams due to proposed CMA competition reforms

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus
  • International

Trending Articles

  • Citroën 2CV returns as a £13,000 electric car, and the timing is no accident

  • The former African gold miner taking on the billionaire Issa brothers

  • Bank of England warns Burnham of UK economy’s ‘big issue’

  • Rachel Reeves to unveil next steps for ring-fencing reform at Mansion House

  • Wimbledon: HMRC set to slap Sinner and Noskova with £1.6m tax bill

More from City PM

  • Apple memory chip warning causes fresh Asia tech sell-off

    Markets
    Apple App Store with UK flag and warning sign about potential scams due to proposed CMA competition reforms
  • Former KPMG chief joins £10m funding round for AI-powered audit challenger

    AI
    Cortea founders Valentin Neumann and Phillipp Hovelmann standing together, with Neumann on the left and Hovelmann on the r...
  • Liz Kendall ramps up push to funnel pension cash into UK startups

    Tech
    Work and Pensions Secretary Liz Kendall is in charge of reforming the state pension and benefits system
  • UK firms ‘bracing for change’ as Trump revives tariff threat over Big Tech tax

    Tech
    Donald Trump addressing media at a press event, wearing a suit and tie, with reporters and cameras in the background.
  • London Tech Week day four: Tech still cares about diversity

    Opinion
    Attendees networking at London Tech Week 2026 showcasing innovation and technology advancements
  • Starmer agrees investment deal with Japan as EU deal questioned

    Politics
    UK and Japan leaders discuss bilateral trade agreements at a high-level government meeting in London.
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
  • Octus Signs Definitive Agreement to Acquire LevPro, Advancing Vision for a Market-Leading, Vertically Integrated Platform for CLO and Private Credit Managers

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook